MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 995 |
Device Problem
Perivalvular Leak (1457)
|
Patient Problems
Aortic Regurgitation (1716); Congestive Heart Failure (1783); Death (1802); Endocarditis (1834); Hemorrhage, Cerebral (1889); Hemostasis (1895); Ischemia (1942); Pneumonia (2011); Sepsis (2067); Pseudoaneurysm (2605)
|
Event Date 05/06/2015 |
Event Type
Injury
|
Manufacturer Narrative
|
Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.(b)(4).Title of article: long term outcomes following freestyle stentless aortic bioprosthesis citation: heart, lung and circulation xx, 1-7, 2015, 10.1016/j.Hlc.2015.05.011 authors: andrew g sherrah, richmond w jeremy,phd, rajesh puranik, paul g bannon, p nicholashendel, matthew s bayfield, michael kwilson, pet the date of publish (b)(6) 2007 used for event date.
|
|
Event Description
|
Medtronic received information via literature review that a study was performed to evaluate freestyle stentless bioprosthesis (fsb) implantation for up to 10 years (serial numbers not provided).The fsb was implanted as a full aortic root replacement in 87.8% patients.The study population included 237 patients, predominantly male with a mean age of 63 years.Among all patients, thirty (30) deaths were reported, which included deaths from: cardiac failure, bleeding, cerebral vascular accident (cva), mesenteric ischemia, sepsis, pneumonia, hypoxic arrest, and unrelated terminal illness.There was no allegation against the valve or its function nor was there any allegation that the valve directly contributed to the patient's death.Among all patients, forty-nine (49) adverse events occurred, which included: hemostasis for intra-operative bleeding, cerebral vascular accident (cva), permanent pacemaker implantation, mild to severe aortic regurgitation (ar), pseudoaneurysm, endocarditis and paravalvular leak (pvl).No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|